AI-designed universal coronavirus vaccine shows safety and immune response in first human trial
TL;DR
Researchers from Cambridge and Southampton used AI to design a ‘super-antigen’ vaccine intended to protect against multiple Sarbeco coronaviruses. In a Phase I trial, the vaccine was safe and elicited immune responses in 39 healthy volunteers when delivered via a needle-free micro-fluid jet, suggesting a potential future-proof solution against current and emerging coronaviruses, though larger and more diverse trials are needed and concerns about AI in medicine remain.
- AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics Fox News
- Preventing the next pandemic using AI-designed vaccines Drug Discovery News
- Needle-free ‘universal vaccine’ could protect from future virus outbreaks healthcare-in-europe.com
- Doctors Inject Human Subjects With First Vaccine Designed by AI Futurism
- A New Vaccine Was Designed by AI and Safey Tested on Humans Healthline
Want the full story? Read the original reporting
Read on Fox News